Effect of selected combination of Ä?yurvedic Treatment drugs in long lasting cough and breathing difficulty as a result of smoking or exposure to smoke.

Effect of selected Ä?yurvedic Treatment Protocol in Chronic Obstructive Pulmonary Disease â?? A Non Randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049925

Enrollment

Registered

2023-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a)Diagnosed COPD, stage 1 & 2 as per GOLD criteria of spirometry (Annexure-VII), attending Out-patient & In-patient department, V.P.S.V Ayurveda College hospital, Kottakkal and OPD of Amala Institute of Medical Sciences, Thrissur b)Participants fit for Snehapana, Virechana (therapeutic purgation) and RasÄ?yana c)Participants providing written consent.

Exclusion criteria

Exclusion criteria: Diagnosed cases of allergic asthma, TB, bronchiectasis, malignancy. Pregnant and lactating women. Current Smokers History of Status asthmaticus / history of recent hospitalization /severe symptoms. Participants with Peak Expiratory Flow Rate <50 %

Design outcomes

Primary

Measure	Time frame
a)Changes in Cough and Breathing difficultyTimepoint: Baseline, 4 weeks, 6 weeks and 8 weeks	—

Secondary

Measure	Time frame
a.Changes in QOL assessed by evaluating score level of SGRQ and CAT Questionnaire. b.Changes in the blood parameters (Hb, TC, DC, ESR, AEC, IgE , LFT & RFT), BODE Index and GOLD spirometric criteria will be assessed before and after the treatment. AFB in suspected cases of TB and X-ray (chest- PA view) will be done before the treatment to exclude TB and bronchiectasisTimepoint: 0th day and 60th day	—

Measure

Time frame

a.Changes in QOL assessed by evaluating score level of SGRQ and CAT Questionnaire. b.Changes in the blood parameters (Hb, TC, DC, ESR, AEC, IgE , LFT & RFT), BODE Index and GOLD spirometric criteria will be assessed before and after the treatment. AFB in suspected cases of TB and X-ray (chest- PA view) will be done before the treatment to exclude TB and bronchiectasisTimepoint: 0th day and 60th day

—

Countries

India

Contacts

Public ContactDr JITHESH M

VPSV AYURVEDA COLLEGE KOTTAKKAL

drvdthomas@gmail.com8547615151

Outcome results